References
- Chopra IJ, Sakane S, Teco GN. A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metah 1991; 72(5): 1113–6
- Chopra IJ. Clinical review 86. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metah 1997; 82(2): 329–34
- Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981; 245(l): 43–5
- Becker KL. Euthyroid sick syndrome. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. 2d ed. Philadelphia: Lippincott, 1995: 1786
- Spratt DI, Pont A, Miller MB, et al. Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 1982; 73(l): 41–8
- Mooradian AD, Reed RL, Osterweil D, et al. Decreased serum triiodothyronine is associated with increased concentrations of tumor necrosis factor. J Clin Endocrinol Metab 1990; 71(5): 1239–42
- Chow CC, Mak TW, Chan CH, et al. Euthyroid sick syndrome in pulmonary berculosis before and after treatment. Ann Clin Biochem 1995; 32(Pt 4): 385–91
- Spencer C, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987; 33(8): 1391–6
- Burmeister LA. Reverse T, does not reliably differentiate hypothyroid sick syndrome from euthyroid sick syndrome. Thyroid 1995; 5(6): 435–41
- Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63(l): 1–8
- Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333(23): 1522–7
- Bennett-Guerrero E, Jimenez JL, White WD, et al, for the Duke T3 study group. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled trial. JAMA 1996; 275(9): 687–92